Results
3048
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3048 companies
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م6.1b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م4.06
7D
-5.1%
1Y
57.4%
Alterity Therapeutics
Market Cap: AU$119.7m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.013
7D
-7.1%
1Y
333.3%
Tibet Weixinkang Medicine
Market Cap: CN¥5.3b
Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.
603676
CN¥12.30
7D
-0.2%
1Y
62.1%
Concord Biotech
Market Cap: ₹173.4b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,657.70
7D
-1.4%
1Y
-9.7%
Boji Medical TechnologyLtd
Market Cap: CN¥4.1b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.82
7D
-0.6%
1Y
49.7%
Vita Life Sciences
Market Cap: AU$135.3m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.42
7D
5.2%
1Y
5.7%
Aether Industries
Market Cap: ₹98.3b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹741.55
7D
0.7%
1Y
-20.7%
Panchsheel Organics
Market Cap: ₹1.7b
Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.
531726
₹147.90
7D
-2.1%
1Y
-47.3%
AstraZeneca
Market Cap: UK£189.0b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£120.90
7D
2.5%
1Y
-4.4%
GSK
Market Cap: UK£59.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£14.76
7D
1.6%
1Y
-10.6%
Niagen Bioscience
Market Cap: US$744.9m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$9.41
7D
-4.9%
1Y
182.6%
Medpace Holdings
Market Cap: US$13.6b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$486.98
7D
2.4%
1Y
45.0%
Evoke Pharma
Market Cap: US$11.0m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.21
7D
-4.4%
1Y
34.6%
Invivyd
Market Cap: US$202.8m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$1.00
7D
0.8%
1Y
17.2%
Hualan Biological Engineering
Market Cap: CN¥30.8b
A biopharmaceutical company, researches, develops, produces, and commercializes blood products, vaccines, and recombinant proteins in China and internationally.
002007
CN¥16.83
7D
-1.6%
1Y
12.7%
Chi Sheng Pharma & Biotech
Market Cap: NT$2.0b
Engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally.
4111
NT$32.65
7D
4.5%
1Y
32.1%
Syngen BiotechLtd
Market Cap: NT$3.3b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$122.50
7D
1.2%
1Y
-8.9%
IOL Chemicals and Pharmaceuticals
Market Cap: ₹28.5b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹96.93
7D
6.8%
1Y
4.1%
Modern Chinese Medicine Group
Market Cap: HK$496.8m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.69
7D
-1.4%
1Y
122.6%
Novartis India
Market Cap: ₹23.0b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹932.40
7D
0.9%
1Y
-14.5%
Standard Chemical & Pharmaceutical
Market Cap: NT$10.1b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$56.60
7D
0.5%
1Y
-12.8%
Procter & Gamble Health
Market Cap: ₹107.3b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹6,465.40
7D
1.6%
1Y
23.0%
Chong Kun Dang Pharmaceutical
Market Cap: ₩1.1t
Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.
A185750
₩81,200.00
7D
1.6%
1Y
-22.9%
Towa Pharmaceutical
Market Cap: JP¥149.2b
Manufactures and sale ethical drugs in Japan.
4553
JP¥3,030.00
7D
4.5%
1Y
2.7%
Yantai Zhenghai Biotechnology
Market Cap: CN¥3.6b
Engages in the research and development, production, and marketing of regenerative medical materials in China.
300653
CN¥20.37
7D
-2.8%
1Y
7.9%
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.30
7D
-2.1%
1Y
-2.9%
Anhui Anke Biotechnology (Group)
Market Cap: CN¥18.6b
Anhui Anke Biotechnology (Group) Co., Ltd.
300009
CN¥11.14
7D
-0.7%
1Y
43.2%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 23.00
7D
-3.6%
1Y
-1.9%
Incyte
Market Cap: US$16.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$86.64
7D
2.4%
1Y
41.4%
Protagonist Therapeutics
Market Cap: US$3.6b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$59.60
7D
2.5%
1Y
41.8%
MannKind
Market Cap: US$1.7b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$5.34
7D
18.9%
1Y
-11.4%
Gland Pharma
Market Cap: ₹311.8b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹1,892.20
7D
1.1%
1Y
-0.7%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥17.1b
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
000403
CN¥18.00
7D
1.7%
1Y
-3.7%
Daihan PharmaceuticalLtd
Market Cap: ₩177.6b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩30,200.00
7D
2.2%
1Y
17.5%
Acutaas Chemicals
Market Cap: ₹120.7b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,474.60
7D
4.9%
1Y
108.3%
BioNote
Market Cap: ₩574.7b
Manufactures and sells in-vitro diagnostic animal medicines in South Korea.
A377740
₩5,670.00
7D
-0.4%
1Y
25.0%